Literature DB >> 24696269

ACE polymorphism and use of ACE inhibitors: effects on memory performance.

Jaqueline B Schuch1, Pamela C Constantin, Vanessa K da Silva, Camila Korb, Daiani P Bamberg, Tatiane J da Rocha, Marilu Fiegenbaum, Alcyr de Oliveira, Luciana A Tisser, Fabiana M de Andrade.   

Abstract

Memory is an important cognition function, being fundamental to the development and independence of individuals. Our aim was to investigate the influence apolipoprotein E (APOE) and angiotensin I-converting enzyme (ACE) polymorphism and ACE inhibitors use, besides their interaction on memory performance of healthy subjects over 50 years. The sample consisted of 205 subjects assessed for five types of episodic memory, using Wechsler Memory Scale-Revised (WMS-R), who answered a questionnaire about drug use and were assessed for the ACE insertion/deletion polymorphism and APOE polymorphism. We found no influence of the APOE gene. The use of ACE inhibitors beneficially influenced learning ability scores (p = 0.02). Besides, I allele carriers of ACE polymorphism showed higher verbal memory scores compared with homozygous DD. Also, we observed an interaction influencing learning ability between the ACE polymorphism and the use of inhibitors, the beneficial influence of the I allele was present only in individuals who make use of ACE inhibitors. We conclude that the ACE gene has influence on memory performance, and that this influence is modulated by ACE inhibitors use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696269      PMCID: PMC4082601          DOI: 10.1007/s11357-014-9646-z

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  42 in total

1.  Association study of susceptibility genes for late-onset Alzheimer's disease in the Japanese population.

Authors:  Tomoyuki Ohara; Toshiharu Ninomiya; Yoichiro Hirakawa; Kyota Ashikawa; Akira Monji; Yutaka Kiyohara; Shigenobu Kanba; Michiaki Kubo
Journal:  Psychiatr Genet       Date:  2012-12       Impact factor: 2.458

2.  Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7.

Authors:  J Lee; S Y Chai; F A Mendelsohn; M J Morris; A M Allen
Journal:  Neuropharmacology       Date:  2001-03       Impact factor: 5.250

3.  Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.

Authors:  Ken Kazama; Josef Anrather; Ping Zhou; Helene Girouard; Kelly Frys; Teresa A Milner; Costantino Iadecola
Journal:  Circ Res       Date:  2004-10-21       Impact factor: 17.367

4.  The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment.

Authors:  P Amouyel; F Richard; D Cottel; C Amant; V Codron; N Helbecque
Journal:  Neurosci Lett       Date:  1996-10-18       Impact factor: 3.046

5.  ACE genotype and cognitive decline in an African-Caribbean population.

Authors:  Robert Stewart; John Powell; Martin Prince; Anthony Mann
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

6.  The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

Authors:  D R Gustafson; L Melchior; E Eriksson; V Sundh; K Blennow; I Skoog
Journal:  Neurobiol Aging       Date:  2008-10-05       Impact factor: 4.673

Review 7.  Prevention of dementia and cerebroprotection with antihypertensive drugs.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

8.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

9.  Roles of Brain Angiotensin II in Cognitive Function and Dementia.

Authors:  Masaki Mogi; Jun Iwanami; Masatsugu Horiuchi
Journal:  Int J Hypertens       Date:  2012-12-11       Impact factor: 2.420

Review 10.  Brain renin angiotensin in disease.

Authors:  M Ian Phillips; Edilamar Menezes de Oliveira
Journal:  J Mol Med (Berl)       Date:  2008-04-02       Impact factor: 4.599

View more
  4 in total

Review 1.  Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.

Authors:  Keenan A Walker; Melinda C Power; Rebecca F Gottesman
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

2.  Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia.

Authors:  Kristen M Ward; A Zarina Kraal; Stephanie A Flowers; Vicki L Ellingrod
Journal:  Pharmacotherapy       Date:  2017-08-02       Impact factor: 4.705

3.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09

4.  Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease.

Authors:  Fabricio Ferreira de Oliveira; Juliana Marília Berretta; Elizabeth Suchi Chen; Marilia Cardoso Smith; Paulo Henrique Ferreira Bertolucci
Journal:  Colomb Med (Cali)       Date:  2016-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.